-
FDA Advisers Meet to Discuss Pfizer’s COVID-19 Pill -
Japan’s Shionogi Says COVID-19 Pill Shows Rapid Clearance of Virus -
Merck Sees 2022 Sales up Nearly 20 Percent, Mostly on New COVID Pill -
Merck Authorizes Indian Pharma Company to Manufacture and Supply Affordable COVID-19 Pills -
Vietnam Says Pfizer, MSD to Grant Its Firms Licenses to Produce COVID-19 Pills -
The Race Between COVID-19 Pills and Vaccines